Moderna (MRNA) Stock Price
$35.53 5.3%
to add to portfolio
AI Score
-
Alternative
4 -
Fundamental
6 -
Technical
3
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Moderna, AI stock picks, stock alerts and much more.
MRNA AI Stock Analysis
Financial Performance
The financial performance of Moderna shows mixed signals. The company's revenue has seen a significant increase by 669.7% from the previous quarter, but it is down by -34.1% year over year. Gross profit also shows a similar pattern with an impressive growth of 1477.6% quarter over quarter but a decline of -28.8% compared to the previous year. The operating income is in negative territory at -$70M, which indicates that the company's expenses are higher than its gross profit; this situation has worsened compared to last year with a decrease of -1266.7%. The EBITDA ratio stands at 0.04, which is relatively low and suggests that profitability might be an issue.
Stock Price
The stock price of Moderna has been on a downward trend recently; it decreased by -1% in the last month and significantly dropped by -59.3% year over year, currently trading at $41.41 per share, well below its 200-day moving average ($84.7). This could indicate bearish sentiment among investors or reflect broader market conditions affecting the sector or industry as a whole.
Alternative Data Signals
The alternative data signals also show some concerning trends for Moderna's stock performance outlook: web traffic is down by -26.7%, job openings have decreased by -20.6%, and there's been a decline in social media followership (Twitter down by -3%, Facebook down slightly by -0/4%). Employee morale seems neutral with only about half (47%) reporting positive business outlook.
Conclusion
In conclusion, based on these factors – financials showing mixed signals, a downtrend in stock price, and negative alternative data signals – the AI analysis for Moderna's stock performance is bearish.
Note: This AI Stock Analysis is based on data as of January 26. Our members can refresh and get access to an up-to-date AI stock analysis.
Sign up
Moderna (MRNA) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Moderna (MRNA), currently trading at $35.53, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About MRNA
-
Moderna, Inc.
-
Symbol
MRNA
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
13.7B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$21.62 2% |
6 |
 |
Inovio Pharmaceuticals INO |
$2.24 0.9% |
2 |
 |
Anavex Life Sciences AVXL |
$8.35 3.8% |
6 |
 |
BridgeBio Pharma BBIO |
$36.85 0.1% |
6 |
 |
Crispr Therapeutics CRSP |
$47.91 5% |
6 |
News
MRNA Alternative Data
Web Traffic
Moderna receives an estimated 261466 monthly visitors to modernatx.com.
-
Web Traffic
261466
-
Change from Previous Month
1.8%
-
3 Month Change
28%
-
YoY Change
28%
Reddit Mentions
Moderna has been mentioned an estimated 33 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
33
-
Daily Change
21.4%
News Mentions
Moderna was mentioned 7 times in the news yesterday.
-
News Mentions
7
-
Daily Change
40%
-
1 Month Change
46.2%
-
3 Month Change
30%
Twitter Followers
Moderna has 145,773 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.5% over the last month.
-
Twitter Followers
145773
-
Daily Change
0%
-
1 Month Change
0.5%
-
3 Month Change
1%
-
YoY Change
1%
Facebook Engagement
Moderna has engaged 148 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
148
-
Daily Change
4.2%
-
1 Month Change
5.7%
-
3 Month Change
190.2%
-
YoY Change
190.2%
Youtube Subscribers
Moderna has 11,900 subscribers on its main Youtube channel.
-
Youtube Subscribers
11900
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0.8%
-
YoY Change
0.8%
LinkedIn Followers
653,492 are following Moderna on LinkedIn, up by 1.1% over the last month.
-
LinkedIn Followers
653492
-
Daily Change
0%
-
1 Month Change
1.1%
-
3 Month Change
3.1%
Job Postings
Moderna has an estimated 116 open job postings, which is down -17.7% over the last month.
-
Job Postings
116
-
Daily Change
4.1%
-
1 Month Change
17.7%
-
3 Month Change
54.9%
-
YoY Change
54.9%
LinkedIn Employees
According to LinkedIn, Moderna has 7,051 employees, up by 0.6% over the last month.
-
LinkedIn Employees
7051
-
Daily Change
0%
-
1 Month Change
0.6%
-
3 Month Change
0.5%
-
YoY Change
0.5%
Business Outlook
-
Business Outlook
47
-
Change from Previous Month
7.8%
-
3 Month Change
0%
-
YoY Change
0%
MRNA Financials
MRNA Key Metrics
-
Total Revenue
$1.9B
-
Net Income
$13M
-
Earnings per Share
$0.0338
-
Free cash flow
-$1.7B
-
EBITDA
$79M
-
EBITDA Ratio
0.0425876
-
Total Assets
$15.8B
MRNA 2-year Revenue & Income
MRNA 2-year Free Cash Flow
MRNA Technicals
MRNA SMA
MRNA RSI
FAQ
What's the current price of Moderna (MRNA) Stock?
The price of an Moderna (MRNA) share is $35.53.
What's the market cap of Moderna?
The current market cap of Moderna is 13.7B.
Should I buy or sell MRNA?
Moderna shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Moderna is better viewed as a hold or accumulate position while waiting for further developments.
Is Moderna a good investment?
The current analysis of Moderna's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Moderna's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Moderna (MRNA) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Moderna stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Moderna (MRNA) that investors often compare it to?
Moderna (MRNA) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Anavex Life Sciences, BridgeBio Pharma and Crispr Therapeutics.
What is the forecast for Moderna's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Moderna's stock price to be around $33.62 in 2026. Starting from the current price of $35.53, this represents a 5.4% change in price, indicating a bearish outlook for the stock.
How to buy Moderna (MRNA) Stock?
Moderna stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Moderna shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.